Wedbush Securities Inc Idera Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 20, 2020
SELL
$1.71 - $2.68 $43,264 - $67,806
-25,301 Closed
0 $0
Q2 2020

Jul 16, 2020
BUY
$1.23 - $2.12 $31,120 - $53,638
25,301 New
25,301 $45,000
Q1 2020

Apr 17, 2020
SELL
$1.06 - $2.15 $17,384 - $35,260
-16,400 Closed
0 $0
Q4 2019

Jan 16, 2020
BUY
$1.45 - $2.79 $23,780 - $45,756
16,400 New
16,400 $30,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email